Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease

Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease

Abstract Convalescent plasma (CP) therapy in COVID-19 disease may improve clinical outcome in severe disease. This pilot study was undertaken to inform feasibility and safety of further definitive studies. This was a prospective, interventional and randomized open label pilot trial in patients with...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Manaf AlQahtani, Abdulkarim Abdulrahman, Abdulrahman Almadani, Salman Yousif Alali, Alaa Mahmood Al Zamrooni, Amal Hamza Hejab, Ronán M. Conroy, Pearl Wasif, Sameer Otoom, Stephen L. Atkin, Manal Abduljalil
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/a115eff395224fdea2740b4a1bd82e47
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares